Ustekinumab
Stories
-
Janssen posts results of Phase 3 ustekinumab trial in pediatric ulcerative colitis
The study, completed in 2025, enrolled 112 pediatric participants with moderately to severely active ulcerative colitis and evaluated ustekinumab induction and maintenance therapy. Results were first posted on ClinicalTrials.gov on October 20, 2026.